Orphan drug designation, or ODD, is valuable on both a humanitarian and a profitability basis. And this company is seeing shares rally following news that it was granted the designation for the...

To read the full story on AllPennyStocks.com, click here.

Cardiol Therapeutics (NASDAQ:CRDL)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Cardiol Therapeutics.
Cardiol Therapeutics (NASDAQ:CRDL)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Cardiol Therapeutics.